Explore the Wonders of Macao: Participate in the “Experience Macao Limited Edition”

EQS Newswire / 26/08/2024 / 14:00 UTC+8 To showcase Macao’s rich tourism resources and unique culture, the Macao Government Tourism Office (MGTO) officially launched the International  “Experience Macao Limited Edition” campaign at an online press conference on August 26 at 11:00 AM (Beijing time). During the conference, MGTO Director Maria Helena de Senna Fernandes, along […]

Sinopec Announces FY2024 Interim Results

EQS Newswire / 25/08/2024 / 19:10 UTC+8 Press release (For immediate release)           Sinopec Delivered Promising 2024 Interim Results   The Board Approved of the “Action of Corporate Value and Return Plan” Proposed to Distribute Cash Dividends of Not Less Than 65% of Annual Profit in Next Three Years   (25 […]

【Press Release】China XLX Announces 2024 Interim Results

EQS Newswire / 25/08/2024 / 16:29 UTC+8 Press Release (For immediate release)   China XLX Announces 2024 Interim Results Quality Improvement, Cost Reduction and Efficiency Enhancement Contributing to Profit Growth   2024 Interim Results Highlights:   The Group’s revenue increased by 0.02% YoY to approximately RMB 12.061 billion; Profit attributable to owners of the parent surged […]

Sun Hung Kai & Co. Announces 2024 Interim Results 

EQS Newswire / 22/08/2024 / 12:00 UTC+8 Conservative positioning continues to drivereturn to profitability    Sun Hung Kai & Co. Limited (Stock Code: 86.HK) (“SHK & Co” or the “Company”, together with its subsidiaries, the “Group”) announces a significant turnaround in its interim results for the period ended 30 June 2024, reflecting the benefits of […]

Sihuan Pharmaceutical (00460.HK): Subsidiary Huisheng Biopharmaceutical Reshapes Diabetes Treatment Landscape With Two Home-Grown Insulin Products

EQS Newswire / 21/08/2024 / 10:07 UTC+8 1. With Two Home-Grown Insulin Products Approved for Marketing, It Leads the Development of The Domestic Insulin MarketOn August 6th, Sihuan Pharmaceutical (00460.HK) announced that Insulin Degludec and Insulin Aspart Injection (trade name: Huiyoujia), developed by its subsidiary Huisheng Biopharmaceutical, was approved for marketing to treat adult type […]

Guoen’s (HKSE:8121) Share Price Doubled after Rights Issue, thanks to Star Investor RaffAello

EQS Newswire / 20/08/2024 / 10:38 UTC+8 Well-run listed companies often achieve remarkable results when they encounter suitable partners in the capital markets. Guoen Holdings Limited (“Guoen”) (HKSE: 8121) is a prime example. In February this year, Guoen announced a 1-for-2 rights issue at HK$1.04 per share, raising HK$17.3 million. The Group offers a range […]

[Press Release] SEG Announces 2024 Interim Results

EQS Newswire / 18/08/2024 / 19:24 UTC+8 Press Release (For immediate release)       SEG Announces 2024 Interim Results Declare to Pay Out Record High Interim Dividends Inclusion in the Hang Seng Composite Index Reflects High Market Recognition of Investment Value   (18 August 2024, Hong Kong) SINOPEC Engineering (Group) Co., Ltd. (“SEG” or […]

AGTech Holdings Limited (8279.HK) Received Regulatory Approval in Relation to Attainment of Controlling Stake in Ant Bank (Macao) Limited

EQS Newswire / 16/08/2024 / 21:48 UTC+8 (Hong Kong, August 16, 2024) – AGTech Holdings Limited (HKEX stock code:8279, hereinafter referred to as “AGTech”) is pleased to announce that on August 16, 2024, Ant Bank (Macao) Limited (“Ant Bank”) has received Macao regulator’s approval in relation to its share transfer and capital injection, after the […]